InsiderSignal.AI

InsiderSignal.ai

ZLAB - Zai Lab Ltd

Insider Sale by Du Ying (Chairperson, CEO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

3 days ago, Du Ying, serving as Chairperson, CEO at Zai Lab Ltd (ZLAB), sold 2,653 shares at $20.45 per share, for a total transaction value of $54,249.00. Following this transaction, Du Ying now holds 1,122,626 shares of ZLAB.

The trade was executed on Monday, April 6, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, April 8, 2026, 2 days after the trade was made.

Zai Lab Ltd operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Du Ying

Du Ying

Chairperson, CEO

Samantha Du (Du Ying), Ph.D. is the Founder, Chairperson, and Chief Executive Officer of Zai Lab Ltd. (NASDAQ: ZLAB; HKEX: 9688), a biopharmaceutical company focused on addressing unmet medical needs globally, a role she has held since founding the company in 2014.[[1]](https://www.marketscreener.com/insider/YING-DU-A0WOF2/)[[3]](https://www.youtube.com/watch?v=G0XYn0t1Nvk)[[5]](https://www.zailaboratory.com/leadership/samantha-du-ph-d/) She is also the Founder and General Partner of Zai Venture Partners, a venture capital firm established in 2017, and serves on the board of directors for JHL Biotech, Inc. and Eden Biologics, Inc.[[1]](https://www.marketscreener.com/insider/YING-DU-A0WOF2/)[[2]](https://q.stock.sohu.com/us/ZLAB_directors.html) Dr. Du's career spans drug development, entrepreneurship, and investment. She began at Pfizer in the US from 1994 to 2001, contributing to multiple products including two FDA-approved drugs and leading the global metabolic licensing group.[[3]](https://www.youtube.com/watch?v=G0XYn0t1Nvk)[[5]](https://www.zailaboratory.com/leadership/samantha-du-ph-d/) She co-founded Hutchison MediPharma in 2002 and served as its CEO, and was Chief Scientific Officer at Hutchison China MediTech (now HUTCHMED).[[1]](https://www.marketscreener.com/insider/YING-DU-A0WOF2/)[[4]](https://www.biocentury.com/article/644050/leadership-innovation-execution-a-conversation-with-zai-s-samantha-du)[[5]](https://www.zailaboratory.com/leadership/samantha-du-ph-d/) Prior to Zai Lab, she was a Venture Partner at Sequoia Capital China and held roles such as Executive Vice President of Healthcare Investment at Hutchison Whampoa (China) Ltd.[[1]](https://www.marketscreener.com/insider/YING-DU-A0WOF2/)[[3]](https://www.youtube.com/watch?v=G0XYn0t1Nvk) Dr. Du holds a Ph.D. in Biochemistry from the University of Cincinnati (1994) and a bachelor's degree from Jilin University (1987).[[1]](https://www.marketscreener.com/insider/YING-DU-A0WOF2/)[[2]](https://q.stock.sohu.com/us/ZLAB_directors.html)

View full insider profile →

Trade Price

$20.45

Quantity

2,653

Total Value

$54,249.00

Shares Owned

1,122,626

Trade Date

Monday, April 6, 2026

3 days ago

SEC Filing Date

Wednesday, April 8, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Zai Lab Ltd

Company Overview

No company information available
View news mentioning ZLAB

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5476954

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime